日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Hyperthermus butylicus V-type ATP synthase alpha chain (atpA), partial CSB-YP382384HSR
CSB-EP382384HSR
CSB-BP382384HSR
CSB-MP382384HSR
CSB-EP382384HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP382385HSR
CSB-EP382385HSR
CSB-BP382385HSR
CSB-MP382385HSR
CSB-EP382385HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus UPF0173 metal-dependent hydrolase Hbut_0886 (Hbut_0886) CSB-YP382386HSR
CSB-EP382386HSR
CSB-BP382386HSR
CSB-MP382386HSR
CSB-EP382386HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Replication factor C large subunit (rfcL) CSB-YP382387HSR
CSB-EP382387HSR
CSB-BP382387HSR
CSB-MP382387HSR
CSB-EP382387HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Tryptophan--tRNA ligase (trpS) CSB-YP382388HSR
CSB-EP382388HSR
CSB-BP382388HSR
CSB-MP382388HSR
CSB-EP382388HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Uridylate kinase (pyrH) CSB-YP382389HSR
CSB-EP382389HSR
CSB-BP382389HSR
CSB-MP382389HSR
CSB-EP382389HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Chromatin protein Cren7 2 (cren7-2) CSB-YP382390HSR
CSB-EP382390HSR
CSB-BP382390HSR
CSB-MP382390HSR
CSB-EP382390HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus GTPase HflX (hflX) CSB-YP382391HSR
CSB-EP382391HSR
CSB-BP382391HSR
CSB-MP382391HSR
CSB-EP382391HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Arginine decarboxylase proenzyme (Hbut_1182) CSB-YP382392HSR
CSB-EP382392HSR
CSB-BP382392HSR
CSB-MP382392HSR
CSB-EP382392HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus 50S ribosomal protein L2P (rpl2p) CSB-YP382393HSR
CSB-EP382393HSR
CSB-BP382393HSR
CSB-MP382393HSR
CSB-EP382393HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus 30S ribosomal protein S4e (rps4e) CSB-YP382394HSR
CSB-EP382394HSR
CSB-BP382394HSR
CSB-MP382394HSR
CSB-EP382394HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus 30S ribosomal protein S5P (rps5p) CSB-YP382395HSR
CSB-EP382395HSR
CSB-BP382395HSR
CSB-MP382395HSR
CSB-EP382395HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Probable RNA 2'-phosphotransferase (kptA) CSB-YP382396HSR
CSB-EP382396HSR
CSB-BP382396HSR
CSB-MP382396HSR
CSB-EP382396HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus RNA 3'-terminal phosphate cyclase (rtcA) CSB-YP382397HSR
CSB-EP382397HSR
CSB-BP382397HSR
CSB-MP382397HSR
CSB-EP382397HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Proteasome subunit beta 2 (psmB2) CSB-YP382398HSR
CSB-EP382398HSR
CSB-BP382398HSR
CSB-MP382398HSR
CSB-EP382398HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus Elongation factor 1-alpha (tuf) CSB-YP382399HSR
CSB-EP382399HSR
CSB-BP382399HSR
CSB-MP382399HSR
CSB-EP382399HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus 50S ribosomal protein L39e (rpl39e) CSB-YP382400HSR
CSB-EP382400HSR
CSB-BP382400HSR
CSB-MP382400HSR
CSB-EP382400HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus 50S ribosomal protein LX (rplX) CSB-YP382401HSR
CSB-EP382401HSR
CSB-BP382401HSR
CSB-MP382401HSR
CSB-EP382401HSR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hyperthermus butylicus UPF0290 protein Hbut_1639 (Hbut_1639), partial CSB-YP382402HSR1
CSB-EP382402HSR1
CSB-BP382402HSR1
CSB-MP382402HSR1
CSB-EP382402HSR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Phosphoribosylformylglycinamidine synthase 2 (purL), partial CSB-YP382403PZB
CSB-EP382403PZB
CSB-BP382403PZB
CSB-MP382403PZB
CSB-EP382403PZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×